Germline <i>TP53</i> Mutations Causing Diamond–Blackfan Anemia: A French Report

Diamond-Blackfan anemia is a rare congenital erythroblastopenia typically caused by mutations in ribosomal protein genes. Recently, gain-of-function mutations in TP53 have been identified as a novel cause of Diamond-Blackfan anemia. We report two French patients who both harbored a heterozygous TP53 deletion (NM_000546.5: c.1077delA; p.(Ser362AlafsTer8)). They exhibited normocytic anemia, transient neutropenia at presentation, and distinct neurological impairments. Neither patient responded to a corticosteroid trial. One patient underwent hematopoietic stem cell transplantation from a matched sibling donor and remained transfusion-independent at last follow-up. This study emphasizes the complexity of TP53-associated Diamond-Blackfan anemia syndrome and presents the only patient to date cured by hematopoietic stem cell transplantation.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2026-05-09
DOI
https://doi.org/10.1002/1545-5017.70363
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Germline TP53 Mutations Causing Diamond–Blackfan Anemia: A French Report

Mélissa Barbati, Ludivine David NGuyen, Audrey Riquet, Rafael Moisan et al.
Pediatric Blood & Cancer
RNA modifications and cancer
article

Germline TP53 Mutations Causing Diamond–Blackfan Anemia: A French Report

Mélissa Barbati, Ludivine David NGuyen, Audrey Riquet, Rafael Moisan, Heloise Chosseler, Benedicte Bruno, Lydie Da Costa
article en

Abstract

Diamond-Blackfan anemia is a rare congenital erythroblastopenia typically caused by mutations in ribosomal protein genes. Recently, gain-of-function mutations in TP53 have been identified as a novel cause of Diamond-Blackfan anemia. We report two French patients who both harbored a heterozygous TP53 deletion (NM_000546.5: c.1077delA; p.(Ser362AlafsTer8)). They exhibited normocytic anemia, transient neutropenia at presentation, and distinct neurological impairments. Neither patient responded to a corticosteroid trial. One patient underwent hematopoietic stem cell transplantation from a matched sibling donor and remained transfusion-independent at last follow-up. This study emphasizes the complexity of TP53-associated Diamond-Blackfan anemia syndrome and presents the only patient to date cured by hematopoietic stem cell transplantation.

Pediatric Blood & Cancer
Inserm (FR), Université Catholique de Lille (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Centre Hospitalier Universitaire de Lille (FR), Institut des Sciences des Plantes de Paris Saclay (FR), Lille’s Cardiology Hospital (FR), Groupe Hospitalier de l'Institut Catholique de Lille (FR), Bicêtre Hospital (FR)
Good health and well-being
Openalex Percentile: Top 8%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.